Delayed Remission With Advanced Therapies Is Not Associated With Worse 1-Year Outcomes in Inflammatory Bowel Disease
About one-sixth of patients achieved delayed remission by week 30. They had comparable one-year outcomes as early remitters. Identifying predictors of delayed remission could help prevent early therapy discontinuation without affecting long-term outcomes.
Authors
- Sara Ghoneim (ORCID: https://orcid.org/0000-0003-4548-6318)
- Ramnik J. Xavier (ORCID: https://orcid.org/0000-0002-5630-5167)
- Ashwin N. Ananthakrishnan (ORCID: https://orcid.org/0000-0002-9436-1821)
- Karan Sachdeva (ORCID: https://orcid.org/0000-0003-4691-7108)
- Leo Boneschansker
- Helena Lau
- Heather Choe
Institutions
- Broad Institute (US)
- Harvard University (US)
- University of Massachusetts Chan Medical School (US)
- Massachusetts General Hospital (US)
- Center for Systems Biology (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2025-10-13
- DOI
- https://doi.org/10.14309/ajg.0000000000003795
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00